nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—arteriole—metabolic syndrome X	0.0395	0.282	CbGeAlD
Zuclopenthixol—Body temperature decreased—Metformin—metabolic syndrome X	0.0276	0.0656	CcSEcCtD
Zuclopenthixol—Hypothermia—Metformin—metabolic syndrome X	0.0276	0.0656	CcSEcCtD
Zuclopenthixol—HTR2A—sympathetic nervous system—metabolic syndrome X	0.0251	0.18	CbGeAlD
Zuclopenthixol—Rhinorrhoea—Metformin—metabolic syndrome X	0.0191	0.0454	CcSEcCtD
Zuclopenthixol—HTR2A—autonomic nervous system—metabolic syndrome X	0.0169	0.121	CbGeAlD
Zuclopenthixol—Nasal congestion—Metformin—metabolic syndrome X	0.0123	0.0293	CcSEcCtD
Zuclopenthixol—Migraine—Metformin—metabolic syndrome X	0.011	0.0263	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Metformin—metabolic syndrome X	0.0104	0.0246	CcSEcCtD
Zuclopenthixol—Breast disorder—Metformin—metabolic syndrome X	0.0101	0.0241	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Metformin—metabolic syndrome X	0.01	0.0239	CcSEcCtD
Zuclopenthixol—HTR2A—artery—metabolic syndrome X	0.00958	0.0685	CbGeAlD
Zuclopenthixol—Sweating increased—Metformin—metabolic syndrome X	0.00945	0.0225	CcSEcCtD
Zuclopenthixol—Clozapine—FMO3—metabolic syndrome X	0.00941	0.177	CrCbGaD
Zuclopenthixol—Neutropenia—Metformin—metabolic syndrome X	0.00907	0.0216	CcSEcCtD
Zuclopenthixol—Drowsiness—Metformin—metabolic syndrome X	0.00865	0.0206	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Metformin—metabolic syndrome X	0.00818	0.0195	CcSEcCtD
Zuclopenthixol—HTR2A—endothelium—metabolic syndrome X	0.0081	0.0578	CbGeAlD
Zuclopenthixol—Oedema peripheral—Metformin—metabolic syndrome X	0.00765	0.0182	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Metformin—metabolic syndrome X	0.00763	0.0181	CcSEcCtD
Zuclopenthixol—HTR2A—blood vessel—metabolic syndrome X	0.00747	0.0533	CbGeAlD
Zuclopenthixol—Eye disorder—Metformin—metabolic syndrome X	0.00725	0.0173	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Metformin—metabolic syndrome X	0.0072	0.0171	CcSEcCtD
Zuclopenthixol—Angiopathy—Metformin—metabolic syndrome X	0.00704	0.0168	CcSEcCtD
Zuclopenthixol—Immune system disorder—Metformin—metabolic syndrome X	0.00701	0.0167	CcSEcCtD
Zuclopenthixol—Malnutrition—Metformin—metabolic syndrome X	0.00676	0.0161	CcSEcCtD
Zuclopenthixol—Erythema—Metformin—metabolic syndrome X	0.00676	0.0161	CcSEcCtD
Zuclopenthixol—Flatulence—Metformin—metabolic syndrome X	0.00666	0.0158	CcSEcCtD
Zuclopenthixol—Vision blurred—Metformin—metabolic syndrome X	0.00637	0.0152	CcSEcCtD
Zuclopenthixol—Tremor—Metformin—metabolic syndrome X	0.00633	0.0151	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Metformin—metabolic syndrome X	0.00627	0.0149	CcSEcCtD
Zuclopenthixol—Malaise—Metformin—metabolic syndrome X	0.00609	0.0145	CcSEcCtD
Zuclopenthixol—Syncope—Metformin—metabolic syndrome X	0.00606	0.0144	CcSEcCtD
Zuclopenthixol—Palpitations—Metformin—metabolic syndrome X	0.00597	0.0142	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Metformin—metabolic syndrome X	0.00594	0.0141	CcSEcCtD
Zuclopenthixol—Hypertension—Metformin—metabolic syndrome X	0.00583	0.0139	CcSEcCtD
Zuclopenthixol—Myalgia—Metformin—metabolic syndrome X	0.00575	0.0137	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00571	0.0136	CcSEcCtD
Zuclopenthixol—Discomfort—Metformin—metabolic syndrome X	0.00568	0.0135	CcSEcCtD
Zuclopenthixol—Shock—Metformin—metabolic syndrome X	0.00542	0.0129	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Metformin—metabolic syndrome X	0.00541	0.0129	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Metformin—metabolic syndrome X	0.0054	0.0128	CcSEcCtD
Zuclopenthixol—Skin disorder—Metformin—metabolic syndrome X	0.00536	0.0127	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Metformin—metabolic syndrome X	0.00533	0.0127	CcSEcCtD
Zuclopenthixol—Anorexia—Metformin—metabolic syndrome X	0.00526	0.0125	CcSEcCtD
Zuclopenthixol—Hypotension—Metformin—metabolic syndrome X	0.00515	0.0123	CcSEcCtD
Zuclopenthixol—ADRA1A—cardiovascular system—metabolic syndrome X	0.00515	0.0368	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00502	0.012	CcSEcCtD
Zuclopenthixol—Paraesthesia—Metformin—metabolic syndrome X	0.00495	0.0118	CcSEcCtD
Zuclopenthixol—Dyspnoea—Metformin—metabolic syndrome X	0.00492	0.0117	CcSEcCtD
Zuclopenthixol—Somnolence—Metformin—metabolic syndrome X	0.0049	0.0117	CcSEcCtD
Zuclopenthixol—Dyspepsia—Metformin—metabolic syndrome X	0.00485	0.0116	CcSEcCtD
Zuclopenthixol—Decreased appetite—Metformin—metabolic syndrome X	0.00479	0.0114	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00476	0.0113	CcSEcCtD
Zuclopenthixol—Fatigue—Metformin—metabolic syndrome X	0.00475	0.0113	CcSEcCtD
Zuclopenthixol—Constipation—Metformin—metabolic syndrome X	0.00472	0.0112	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Metformin—metabolic syndrome X	0.00454	0.0108	CcSEcCtD
Zuclopenthixol—ADRA1A—adipose tissue—metabolic syndrome X	0.00454	0.0324	CbGeAlD
Zuclopenthixol—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00451	0.0107	CcSEcCtD
Zuclopenthixol—Abdominal pain—Metformin—metabolic syndrome X	0.00436	0.0104	CcSEcCtD
Zuclopenthixol—Asthenia—Metformin—metabolic syndrome X	0.00396	0.00941	CcSEcCtD
Zuclopenthixol—Nefazodone—HTR2C—metabolic syndrome X	0.00392	0.0738	CrCbGaD
Zuclopenthixol—Pruritus—Metformin—metabolic syndrome X	0.0039	0.00928	CcSEcCtD
Zuclopenthixol—Diarrhoea—Metformin—metabolic syndrome X	0.00377	0.00898	CcSEcCtD
Zuclopenthixol—Dizziness—Metformin—metabolic syndrome X	0.00365	0.00868	CcSEcCtD
Zuclopenthixol—Trazodone—HTR2C—metabolic syndrome X	0.00363	0.0683	CrCbGaD
Zuclopenthixol—HRH1—adipose tissue—metabolic syndrome X	0.00352	0.0251	CbGeAlD
Zuclopenthixol—Vomiting—Metformin—metabolic syndrome X	0.00351	0.00834	CcSEcCtD
Zuclopenthixol—Rash—Metformin—metabolic syndrome X	0.00348	0.00827	CcSEcCtD
Zuclopenthixol—Dermatitis—Metformin—metabolic syndrome X	0.00347	0.00827	CcSEcCtD
Zuclopenthixol—ADRA2A—adipose tissue—metabolic syndrome X	0.00345	0.0247	CbGeAlD
Zuclopenthixol—Headache—Metformin—metabolic syndrome X	0.00345	0.00822	CcSEcCtD
Zuclopenthixol—Thiothixene—HTR2C—metabolic syndrome X	0.0034	0.064	CrCbGaD
Zuclopenthixol—HTR2A—cardiovascular system—metabolic syndrome X	0.00333	0.0238	CbGeAlD
Zuclopenthixol—Nausea—Metformin—metabolic syndrome X	0.00328	0.00779	CcSEcCtD
Zuclopenthixol—HTR2A—kidney—metabolic syndrome X	0.00326	0.0233	CbGeAlD
Zuclopenthixol—Prochlorperazine—HTR2C—metabolic syndrome X	0.00325	0.0612	CrCbGaD
Zuclopenthixol—ADRA1A—liver—metabolic syndrome X	0.00319	0.0228	CbGeAlD
Zuclopenthixol—Amoxapine—HTR2C—metabolic syndrome X	0.00299	0.0563	CrCbGaD
Zuclopenthixol—CYP2D6—kidney—metabolic syndrome X	0.00297	0.0212	CbGeAlD
Zuclopenthixol—Fluphenazine—HTR2C—metabolic syndrome X	0.00294	0.0553	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2C—metabolic syndrome X	0.00267	0.0504	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2C—metabolic syndrome X	0.00253	0.0477	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR2C—metabolic syndrome X	0.00235	0.0442	CrCbGaD
Zuclopenthixol—Loxapine—HTR2C—metabolic syndrome X	0.00233	0.044	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2C—metabolic syndrome X	0.00232	0.0438	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2C—metabolic syndrome X	0.00228	0.0429	CrCbGaD
Zuclopenthixol—HTR2A—liver—metabolic syndrome X	0.00206	0.0147	CbGeAlD
Zuclopenthixol—Clozapine—HTR2C—metabolic syndrome X	0.00196	0.0369	CrCbGaD
Zuclopenthixol—CYP2D6—liver—metabolic syndrome X	0.00188	0.0134	CbGeAlD
Zuclopenthixol—Chlorpromazine—HTR2C—metabolic syndrome X	0.00184	0.0347	CrCbGaD
Zuclopenthixol—Thioproperazine—ALB—metabolic syndrome X	0.0015	0.0284	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—metabolic syndrome X	0.00148	0.0279	CrCbGaD
Zuclopenthixol—Pipotiazine—ALB—metabolic syndrome X	0.00148	0.0279	CrCbGaD
Zuclopenthixol—Chlorpromazine—ALB—metabolic syndrome X	0.000803	0.0151	CrCbGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOC3—metabolic syndrome X	0.000171	0.000442	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000171	0.000441	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000171	0.000441	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000169	0.000436	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000168	0.000435	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—LPL—metabolic syndrome X	0.000168	0.000433	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000167	0.000433	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—HMGCR—metabolic syndrome X	0.000167	0.000431	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GOT2—metabolic syndrome X	0.000167	0.000431	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—G6PD—metabolic syndrome X	0.000164	0.000425	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IRS1—metabolic syndrome X	0.000162	0.00042	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	0.000161	0.000416	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	0.00016	0.000415	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR2C—metabolic syndrome X	0.00016	0.000414	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOC3—metabolic syndrome X	0.000159	0.000411	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AGT—metabolic syndrome X	0.000158	0.000408	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000158	0.000407	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000157	0.000406	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GCKR—metabolic syndrome X	0.000157	0.000405	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LPA—metabolic syndrome X	0.000157	0.000405	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF2—metabolic syndrome X	0.000156	0.000402	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000155	0.000402	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—INS—metabolic syndrome X	0.000155	0.000402	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AGT—metabolic syndrome X	0.000155	0.000401	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CYBA—metabolic syndrome X	0.000155	0.000401	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AGT—metabolic syndrome X	0.000155	0.0004	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000154	0.000399	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CCL2—metabolic syndrome X	0.000153	0.000396	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CYBA—metabolic syndrome X	0.000153	0.000394	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CYBA—metabolic syndrome X	0.000152	0.000394	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AGT—metabolic syndrome X	0.000152	0.000393	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	0.000152	0.000393	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GHRL—metabolic syndrome X	0.000152	0.000392	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APOB—metabolic syndrome X	0.000151	0.000391	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IGF1—metabolic syndrome X	0.00015	0.000389	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOA5—metabolic syndrome X	0.00015	0.000389	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000149	0.000386	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GHRL—metabolic syndrome X	0.000149	0.000386	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GHRL—metabolic syndrome X	0.000149	0.000385	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ABCA1—metabolic syndrome X	0.000149	0.000384	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—SLC2A4—metabolic syndrome X	0.000149	0.000384	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL5—metabolic syndrome X	0.000148	0.000382	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000147	0.00038	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GHRL—metabolic syndrome X	0.000146	0.000378	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LPL—metabolic syndrome X	0.000144	0.000373	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GOT1—metabolic syndrome X	0.000144	0.000372	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GGT1—metabolic syndrome X	0.000144	0.000372	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CNR1—metabolic syndrome X	0.000144	0.000372	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AGT—metabolic syndrome X	0.000143	0.000371	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000143	0.000371	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000143	0.000369	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CNR1—metabolic syndrome X	0.000141	0.000366	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AGT—metabolic syndrome X	0.000141	0.000365	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CNR1—metabolic syndrome X	0.000141	0.000365	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—APOE—metabolic syndrome X	0.00014	0.000363	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—LEP—metabolic syndrome X	0.00014	0.000363	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	0.00014	0.000361	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—APOA1—metabolic syndrome X	0.000139	0.000359	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CYBA—metabolic syndrome X	0.000139	0.000359	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000138	0.000358	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NOS3—metabolic syndrome X	0.000136	0.000353	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GHRL—metabolic syndrome X	0.000136	0.000351	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCL2—metabolic syndrome X	0.00013	0.000336	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CNR1—metabolic syndrome X	0.000129	0.000333	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000128	0.000331	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000128	0.00033	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IRS1—metabolic syndrome X	0.000125	0.000324	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	0.000125	0.000324	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000125	0.000324	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LIPC—metabolic syndrome X	0.000124	0.000322	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GCK—metabolic syndrome X	0.000124	0.000322	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOC3—metabolic syndrome X	0.000124	0.00032	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AGT—metabolic syndrome X	0.000123	0.000319	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—APOB—metabolic syndrome X	0.000122	0.000316	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LEP—metabolic syndrome X	0.000121	0.000313	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APOE—metabolic syndrome X	0.000121	0.000313	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CETP—metabolic syndrome X	0.00012	0.000311	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—INS—metabolic syndrome X	0.00012	0.00031	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APOA1—metabolic syndrome X	0.00012	0.000309	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	0.000119	0.000309	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	0.000119	0.000307	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCL2—metabolic syndrome X	0.000118	0.000305	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF2—metabolic syndrome X	0.000117	0.000304	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000117	0.000302	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—LPL—metabolic syndrome X	0.000117	0.000302	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000116	0.000301	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF1—metabolic syndrome X	0.000116	0.0003	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF2—metabolic syndrome X	0.000116	0.000299	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF2—metabolic syndrome X	0.000115	0.000298	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	0.000115	0.000297	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—metabolic syndrome X	0.000115	0.000297	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APOB—metabolic syndrome X	0.000114	0.000295	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000113	0.000293	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOB—metabolic syndrome X	0.000112	0.00029	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOB—metabolic syndrome X	0.000112	0.00029	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	0.000112	0.000289	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL5—metabolic syndrome X	0.000111	0.000288	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000111	0.000287	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CD36—metabolic syndrome X	0.000111	0.000286	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00011	0.000285	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	0.00011	0.000284	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL5—metabolic syndrome X	0.00011	0.000283	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL5—metabolic syndrome X	0.000109	0.000283	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000109	0.000282	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000109	0.000282	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LPL—metabolic syndrome X	0.000109	0.000282	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	0.000109	0.000281	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GOT2—metabolic syndrome X	0.000109	0.000281	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IRS1—metabolic syndrome X	0.000108	0.000279	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	0.000107	0.000278	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LPL—metabolic syndrome X	0.000107	0.000277	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LPL—metabolic syndrome X	0.000107	0.000277	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000107	0.000276	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—AKT1—metabolic syndrome X	0.000106	0.000274	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NOS3—metabolic syndrome X	0.000105	0.000272	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	0.000105	0.000272	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	0.000105	0.000271	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—INS—metabolic syndrome X	0.000103	0.000267	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PPARA—metabolic syndrome X	0.000103	0.000266	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	0.000102	0.000264	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL2—metabolic syndrome X	0.000102	0.000263	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF1—metabolic syndrome X	9.99e-05	0.000258	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AGT—metabolic syndrome X	9.97e-05	0.000258	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	9.97e-05	0.000258	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	9.93e-05	0.000257	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—APOE—metabolic syndrome X	9.77e-05	0.000253	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	9.75e-05	0.000252	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	9.68e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	9.68e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—APOA1—metabolic syndrome X	9.66e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SERPINE1—metabolic syndrome X	9.49e-05	0.000245	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GGT1—metabolic syndrome X	9.38e-05	0.000242	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GOT1—metabolic syndrome X	9.38e-05	0.000242	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AGT—metabolic syndrome X	9.32e-05	0.000241	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	9.17e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AGT—metabolic syndrome X	9.15e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LEP—metabolic syndrome X	9.13e-05	0.000236	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APOE—metabolic syndrome X	9.13e-05	0.000236	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NOS3—metabolic syndrome X	9.06e-05	0.000234	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	9.02e-05	0.000233	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AKT1—metabolic syndrome X	9.02e-05	0.000233	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—metabolic syndrome X	9.01e-05	0.000233	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	8.98e-05	0.000232	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	8.98e-05	0.000232	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	8.98e-05	0.000232	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—metabolic syndrome X	8.96e-05	0.000232	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOE—metabolic syndrome X	8.96e-05	0.000232	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	8.88e-05	0.00023	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—metabolic syndrome X	8.88e-05	0.00023	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	8.86e-05	0.000229	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	8.8e-05	0.000227	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	8.8e-05	0.000227	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	8.69e-05	0.000225	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PPARG—metabolic syndrome X	8.51e-05	0.00022	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—INS—metabolic syndrome X	8.35e-05	0.000216	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	8.34e-05	0.000216	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	8.3e-05	0.000215	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	8.19e-05	0.000212	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	8.17e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	8.17e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	8.14e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	8.08e-05	0.000209	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	8.01e-05	0.000207	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	8e-05	0.000207	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOB—metabolic syndrome X	7.96e-05	0.000206	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	7.85e-05	0.000203	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—INS—metabolic syndrome X	7.8e-05	0.000202	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.76e-05	0.000201	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	7.74e-05	0.0002	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—INS—metabolic syndrome X	7.67e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	7.67e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—INS—metabolic syndrome X	7.66e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—metabolic syndrome X	7.65e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	7.64e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LPL—metabolic syndrome X	7.6e-05	0.000196	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	7.55e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	7.54e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	7.53e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	7.51e-05	0.000194	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	7.42e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	7.41e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	7.39e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—metabolic syndrome X	7.32e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	7.29e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	7.27e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CD36—metabolic syndrome X	7.22e-05	0.000187	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.16e-05	0.000185	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	7.05e-05	0.000182	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.05e-05	0.000182	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.03e-05	0.000182	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	6.98e-05	0.000181	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	6.96e-05	0.00018	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.9e-05	0.000178	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	6.87e-05	0.000178	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	6.84e-05	0.000177	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—metabolic syndrome X	6.79e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	6.75e-05	0.000175	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	6.73e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	6.71e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARA—metabolic syndrome X	6.71e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	6.7e-05	0.000173	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	6.59e-05	0.00017	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AGT—metabolic syndrome X	6.5e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.41e-05	0.000166	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOE—metabolic syndrome X	6.37e-05	0.000165	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOA1—metabolic syndrome X	6.3e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	6.27e-05	0.000162	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	6.12e-05	0.000158	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	5.99e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	5.86e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	5.77e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.77e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	5.75e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	5.68e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	5.66e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.65e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	5.56e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARG—metabolic syndrome X	5.55e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—INS—metabolic syndrome X	5.44e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	5.32e-05	0.000138	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.25e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—metabolic syndrome X	5.24e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	5.24e-05	0.000135	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	5.23e-05	0.000135	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	5.16e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	5.13e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—metabolic syndrome X	4.99e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	4.84e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—metabolic syndrome X	4.77e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	4.76e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	4.52e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—metabolic syndrome X	4.51e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.45e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	4.44e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	4.36e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	4.36e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	4.16e-05	0.000108	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	4.05e-05	0.000105	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—metabolic syndrome X	3.41e-05	8.81e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AKT1—metabolic syndrome X	3.37e-05	8.7e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	3.35e-05	8.67e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—metabolic syndrome X	3.35e-05	8.65e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	3.28e-05	8.49e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.14e-05	8.13e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.09e-05	8e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.09e-05	7.98e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	3.05e-05	7.89e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.03e-05	7.83e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	2.81e-05	7.28e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.19e-05	5.67e-05	CbGpPWpGaD
